These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19126291)

  • 1. Cancer, chitosan nanoparticles and catalytic nucleic acids.
    Tan ML; Choong PF; Dass CR
    J Pharm Pharmacol; 2009 Jan; 61(1):3-12. PubMed ID: 19126291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity.
    Dass CR; Friedhuber AM; Khachigian LM; Dunstan DE; Choong PF
    J Microencapsul; 2008 Sep; 25(6):421-5. PubMed ID: 18465314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional gene silencing mediated by chitosan/siRNA nanocomplexes.
    Ji AM; Su D; Che O; Li WS; Sun L; Zhang ZY; Yang B; Xu F
    Nanotechnology; 2009 Oct; 20(40):405103. PubMed ID: 19752491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review: doxorubicin delivery systems based on chitosan for cancer therapy.
    Tan ML; Choong PF; Dass CR
    J Pharm Pharmacol; 2009 Feb; 61(2):131-42. PubMed ID: 19178759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of optimal sites for TGFB1 gene silencing by chitosan-TPP nanoparticle-mediated delivery of shRNA.
    Wang SL; Yao HH; Guo LL; Dong L; Li SG; Gu YP; Qin ZH
    Cancer Genet Cytogenet; 2009 Apr; 190(1):8-14. PubMed ID: 19264227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery.
    Lee DW; Yun KS; Ban HS; Choe W; Lee SK; Lee KY
    J Control Release; 2009 Oct; 139(2):146-52. PubMed ID: 19567259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
    Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy.
    Hallaj-Nezhadi S; Lotfipour F; Dass CR
    Pharmazie; 2010 Dec; 65(12):855-9. PubMed ID: 21284252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluronic/chitosan shell cross-linked nanocapsules encapsulating magnetic nanoparticles.
    Bae KH; Ha YJ; Kim C; Lee KR; Park TG
    J Biomater Sci Polym Ed; 2008; 19(12):1571-83. PubMed ID: 19017471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery.
    Gary DJ; Puri N; Won YY
    J Control Release; 2007 Aug; 121(1-2):64-73. PubMed ID: 17588702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the development of siRNA-based therapeutics for cancer.
    Shen Y
    IDrugs; 2008 Aug; 11(8):572-8. PubMed ID: 18683092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of small interfering RNA: approaching effective cancer therapies.
    Pirollo KF; Chang EH
    Cancer Res; 2008 Mar; 68(5):1247-50. PubMed ID: 18316585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
    Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
    Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
    Li SD; Huang L
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release.
    Kunisawa J; Masuda T; Katayama K; Yoshikawa T; Tsutsumi Y; Akashi M; Mayumi T; Nakagawa S
    J Control Release; 2005 Jul; 105(3):344-53. PubMed ID: 15936842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of siRNA from lyophilized polymeric surfaces.
    Andersen MØ; Howard KA; Paludan SR; Besenbacher F; Kjems J
    Biomaterials; 2008 Feb; 29(4):506-12. PubMed ID: 17950838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment.
    Lee SJ; Huh MS; Lee SY; Min S; Lee S; Koo H; Chu JU; Lee KE; Jeon H; Choi Y; Choi K; Byun Y; Jeong SY; Park K; Kim K; Kwon IC
    Angew Chem Int Ed Engl; 2012 Jul; 51(29):7203-7. PubMed ID: 22696263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan/VEGF-sIRNA nanoparticle for gene silencing.
    Yang Y; Liu X; Zhang D; Yu W; Lv G; Xie H; Zheng J; Ma X
    J Control Release; 2011 Nov; 152 Suppl 1():e160-1. PubMed ID: 22195822
    [No Abstract]   [Full Text] [Related]  

  • 19. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-mediated orally delivered nucleic acids: a gutful of gene therapy.
    Dass CR; Choong PF
    J Drug Target; 2008 May; 16(4):257-61. PubMed ID: 18446603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.